Review



nmdar non competitive antagonist  (Alomone Labs)


Bioz Verified Symbol Alomone Labs is a verified supplier
Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    Alomone Labs nmdar non competitive antagonist
    Nmdar Non Competitive Antagonist, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 78 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nmdar non competitive antagonist/product/Alomone Labs
    Average 95 stars, based on 78 article reviews
    nmdar non competitive antagonist - by Bioz Stars, 2026-02
    95/100 stars

    Images



    Similar Products

    nmdar non competitive antagonist  (Alomone Labs)
    95
    Alomone Labs nmdar non competitive antagonist
    Nmdar Non Competitive Antagonist, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nmdar non competitive antagonist/product/Alomone Labs
    Average 95 stars, based on 1 article reviews
    nmdar non competitive antagonist - by Bioz Stars, 2026-02
    95/100 stars
    		  Buy from Supplier
    potent, non-competitive irreversible nmdar antagonist mk-801  (Tocris)
    90
    Tocris potent, non-competitive irreversible nmdar antagonist mk-801
    Potent, Non Competitive Irreversible Nmdar Antagonist Mk 801, supplied by Tocris, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/potent, non-competitive irreversible nmdar antagonist mk-801/product/Tocris
    Average 90 stars, based on 1 article reviews
    potent, non-competitive irreversible nmdar antagonist mk-801 - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    selective non-competitive nmdar antagonist mk-801 (m107)  (Millipore)
    90
    Millipore selective non-competitive nmdar antagonist mk-801 (m107)
    Immunohistochemical staining for Nestin in the subventricular zone at different time points (2, 6, 24 and 48 h) after hypoxic-ischemic injury in the control, sham and hypoxic-ischemia groups. MK, <t>MK-801;</t> Ro, Ro25-6981; NVP, NVP-AAM077.
    Selective Non Competitive Nmdar Antagonist Mk 801 (M107), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/selective non-competitive nmdar antagonist mk-801 (m107)/product/Millipore
    Average 90 stars, based on 1 article reviews
    selective non-competitive nmdar antagonist mk-801 (m107) - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    non-competitive nmdar antagonist  (Mitochon Pharmaceuticals)
    90
    Mitochon Pharmaceuticals non-competitive nmdar antagonist
    Immunohistochemical staining for Nestin in the subventricular zone at different time points (2, 6, 24 and 48 h) after hypoxic-ischemic injury in the control, sham and hypoxic-ischemia groups. MK, <t>MK-801;</t> Ro, Ro25-6981; NVP, NVP-AAM077.
    Non Competitive Nmdar Antagonist, supplied by Mitochon Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/non-competitive nmdar antagonist/product/Mitochon Pharmaceuticals
    Average 90 stars, based on 1 article reviews
    non-competitive nmdar antagonist - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Immunohistochemical staining for Nestin in the subventricular zone at different time points (2, 6, 24 and 48 h) after hypoxic-ischemic injury in the control, sham and hypoxic-ischemia groups. MK, MK-801; Ro, Ro25-6981; NVP, NVP-AAM077.

    Journal: Molecular Medicine Reports

    Article Title: NMDA receptors promote neurogenesis in the neonatal rat subventricular zone following hypoxic-ischemic injury

    doi: 10.3892/mmr.2015.4501

    Figure Lengend Snippet: Immunohistochemical staining for Nestin in the subventricular zone at different time points (2, 6, 24 and 48 h) after hypoxic-ischemic injury in the control, sham and hypoxic-ischemia groups. MK, MK-801; Ro, Ro25-6981; NVP, NVP-AAM077.

    Article Snippet: Selective non-competitive NMDAR antagonist MK-801 (M107), NR2A antagonist NVP-AAM077 (P1999), and NR2B antagonist Ro25-6981 (R7150) were purchased from Sigma-Aldrich (St. Louis, MO, USA).

    Techniques: Immunohistochemical staining, Staining

    Comparison of the number of integrated optical density (IOD) value of Nestin-positive cells in the subventricular zone (SVZ) at different time points (2, 6, 24 and 48 h) after hypoxic-ischemic injury in the sham group, hypoxic-ischemia (labeled 'model') group, hypoxic-ischemia+treatment with MK-801 group, hypoxic-ischemia+treatment with Ro25-6981 group, and hypoxic-ischemia+treatment with NVP-AAM077 group. Data are presented as mean ± standard deviation. Positive cell counts in five 100×100 μ m 2 areas in the SVZ of three serially sectioned brains at each tested time point. * P<0.05 and ** P<0.01 vs. hypoxic-ischemia group. # P<0.05 and ## P<0.01 vs. hypoxic-ischemia+treatment with MK group.

    Journal: Molecular Medicine Reports

    Article Title: NMDA receptors promote neurogenesis in the neonatal rat subventricular zone following hypoxic-ischemic injury

    doi: 10.3892/mmr.2015.4501

    Figure Lengend Snippet: Comparison of the number of integrated optical density (IOD) value of Nestin-positive cells in the subventricular zone (SVZ) at different time points (2, 6, 24 and 48 h) after hypoxic-ischemic injury in the sham group, hypoxic-ischemia (labeled 'model') group, hypoxic-ischemia+treatment with MK-801 group, hypoxic-ischemia+treatment with Ro25-6981 group, and hypoxic-ischemia+treatment with NVP-AAM077 group. Data are presented as mean ± standard deviation. Positive cell counts in five 100×100 μ m 2 areas in the SVZ of three serially sectioned brains at each tested time point. * P<0.05 and ** P<0.01 vs. hypoxic-ischemia group. # P<0.05 and ## P<0.01 vs. hypoxic-ischemia+treatment with MK group.

    Article Snippet: Selective non-competitive NMDAR antagonist MK-801 (M107), NR2A antagonist NVP-AAM077 (P1999), and NR2B antagonist Ro25-6981 (R7150) were purchased from Sigma-Aldrich (St. Louis, MO, USA).

    Techniques: Labeling, Standard Deviation

    Immunohistochemical staining for DCX in the subventricular zone at different time points (2, 6, 24 and 48 h) after hypoxic-ischemic injury in the control, sham and hypoxic-ischemia groups. DCX, Nestin and doublecortin; MK, MK-801; Ro, Ro25-6981; NVP, NVP-AAM077.

    Journal: Molecular Medicine Reports

    Article Title: NMDA receptors promote neurogenesis in the neonatal rat subventricular zone following hypoxic-ischemic injury

    doi: 10.3892/mmr.2015.4501

    Figure Lengend Snippet: Immunohistochemical staining for DCX in the subventricular zone at different time points (2, 6, 24 and 48 h) after hypoxic-ischemic injury in the control, sham and hypoxic-ischemia groups. DCX, Nestin and doublecortin; MK, MK-801; Ro, Ro25-6981; NVP, NVP-AAM077.

    Article Snippet: Selective non-competitive NMDAR antagonist MK-801 (M107), NR2A antagonist NVP-AAM077 (P1999), and NR2B antagonist Ro25-6981 (R7150) were purchased from Sigma-Aldrich (St. Louis, MO, USA).

    Techniques: Immunohistochemical staining, Staining

    Comparison of the number of DCX-positive cells in the subventricular zone (SVZ) at different time points (2, 6, 24 and 48 h) after hypoxic-ischemic in the sham group, hypoxic-ischemia (labeled 'model') group, hypoxic-ischemia+treatment with MK-801 group, hypoxic-ischemia+treatment with Ro25-6981 group, and hypoxic-ischemia+treatment with NVP-AAM077 group. Data are presented as mean ± standard deviation. Positive cell counts in five 100×100 μ m 2 areas in the SVZ of three serially sectioned brains at each tested time point. * P<0.05, ** P<0.01, and △ P<0.001 vs. hypoxic-ischemia group. #P<0.05, ## P<0.01, and ★ P<0.001 vs. hypoxic-ischemia+treatment with MK group.

    Journal: Molecular Medicine Reports

    Article Title: NMDA receptors promote neurogenesis in the neonatal rat subventricular zone following hypoxic-ischemic injury

    doi: 10.3892/mmr.2015.4501

    Figure Lengend Snippet: Comparison of the number of DCX-positive cells in the subventricular zone (SVZ) at different time points (2, 6, 24 and 48 h) after hypoxic-ischemic in the sham group, hypoxic-ischemia (labeled 'model') group, hypoxic-ischemia+treatment with MK-801 group, hypoxic-ischemia+treatment with Ro25-6981 group, and hypoxic-ischemia+treatment with NVP-AAM077 group. Data are presented as mean ± standard deviation. Positive cell counts in five 100×100 μ m 2 areas in the SVZ of three serially sectioned brains at each tested time point. * P<0.05, ** P<0.01, and △ P<0.001 vs. hypoxic-ischemia group. #P<0.05, ## P<0.01, and ★ P<0.001 vs. hypoxic-ischemia+treatment with MK group.

    Article Snippet: Selective non-competitive NMDAR antagonist MK-801 (M107), NR2A antagonist NVP-AAM077 (P1999), and NR2B antagonist Ro25-6981 (R7150) were purchased from Sigma-Aldrich (St. Louis, MO, USA).

    Techniques: Labeling, Standard Deviation